Search
for
Sort by
Research 30 of 1000+
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Emerging drugs for alopecia areata: JAK inhibitors
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia areata: Time for position statement to include new systemic therapeutic advances
- Efficacy and safety of janus kinase inhibitors in the treatment of alopecia areata in children
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- Systemic Therapies for Pediatric Alopecia Areata.
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Systemic immunotherapies
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Alopecia Areata: Unseen Burdens and Unmet Needs – Comment on ‘The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy’
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- New drugs under investigation for the treatment of alopecias